<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./PMC6613496/results/search/funders/results.xml">
  <result pre="Laboratory for Advanced Therapies Ferrara Italy Edited by: Ioanna Andreadou," exact="National and Kapodistrian University of Athens," post="Greece Reviewed by: Michelino Di Rosa, University of Catania,"/>
  <result pre="Michelino Di Rosa, University of Catania, Italy; Kyle David Fink," exact="University of California," post="Davis, United States *Correspondence: Selene Ingusci, selene.ingusci@unife.it This article"/>
  <result pre="central nervous system viral vector gene regulation brain disease Funding" exact="European Commission" post="10.13039/501100000780 fig-count: table-count: equation-count: ref-count: page-count: word-count: Introduction Even"/>
  <result pre="expression ( Hock and Meister, 2008). In 2018, the US" exact="Food and Drug Administration" post="approved Patisiran, the first ever RNAi therapy licensed for"/>
  <result pre="with the potential to treat neurovascular and neurological diseases ." exact="EMBO" post="Mol. Med. 8 ( 6), 609– 625. 10.15252/emmm.201506078 27137490"/>
  <result pre="576, 73– 78. 10.1016/j.neulet.2014.05.044 24882721 Mendell J. R. Al-Zaidy S." exact="Shell" post="R. Arnold W. D. Rodino-Klapac L. R. Prior T."/>
  <result pre="of large genes to the retina by dual AAV vectors." exact="EMBO" post="Mol. Med. 6 ( 2), 194– 211. 10.1002/emmm.201302948 24150896"/>
 </snippets>
</snippetsTree>
